Anders Hultman

(Mr. Anders Hultman)

Currently holds positions in AroCell AB (publ) and Calliditas Therapeutics AB

Positions

Position Company Period
Chief Financial Officer AroCell AB (publ) Dec. 1, 2018 -
Chief Financial Officer Calliditas Therapeutics AB None -
Anders Hultman's trades of AroCell AB (publ)'s stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-11 2022-05-10
B Purchase
90,000
0.45
SEK 4,167 		90,000 0.45 SEK 40,500
2022-05-09 2022-05-09
B Purchase
460,000
0.48
SEK 22,719 		460,000 0.48 SEK 220,800
2022-05-03 2022-05-03
B Purchase
25,000
0.50
SEK 1,278 		25,000 0.50 SEK 12,425
2021-01-19 2021-01-19
B Purchase
20,000
2.67
SEK 5,485 		20,000 2.67 SEK 53,312
2019-12-06 2019-12-04
B Purchase
60,000
1.50
SEK 9,260 		60,000 1.50 SEK 90,000
2019-11-27 2019-11-26
B Purchase
60,000
0.01
SEK 54 		60,000 0.01 SEK 522
2019-11-26 2019-11-26
B Purchase
60,000
0.01
SEK 54 		60,000 0.01 SEK 522
2018-12-05 2018-12-05
B Purchase
7,831
2.24
SEK 1,805 		7,831 2.24 SEK 17,541
2018-11-28 2018-11-28
B Purchase
10,000
2.51
SEK 2,583 		10,000 2.51 SEK 25,100
2018-11-21 2018-11-21
B Purchase
10,000
2.50
SEK 2,572 		10,000 2.50 SEK 25,000
2018-11-15 2018-11-15
B Purchase
7,400
2.73
SEK 2,079 		7,400 2.73 SEK 20,202
2018-11-14 2018-11-14
B Purchase
20,000
3.10
SEK 6,379 		20,000 3.10 SEK 62,000
// ... existing code ... // ... rest of the file ...